Lipocine Inc. — Director's Dealing 2020

Dec 29, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Lipocine Inc. (LPCN)
CIK: 0001535955
Period of Report: 2020-12-28

Reporting Person: Patel Mahesh V. (Director, Chief Executive Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-12-28	Stock Option (Right to Buy)	$1.37	J	275000	Disposed	2030-12-15	Common Stock (275000)	Direct

Footnotes

F1: On December 15, 2020, the issuer granted to the reporting person, under the issuer's stock incentive plan, options to purchase 375,000 shares of the issuer's common stock. On December 28, 2020, the issuer rescinded and cancelled 275,000 of the options granted, for no consideration.